CompletedPhase 1NCT00301951
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Thomas G. Martin, MDUniversity of California, San Francisco
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 7 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2004 – 2009
Study locations (1)
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00301951 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.